See more : Playgram Co., Ltd. (009810.KS) Income Statement Analysis – Financial Results
Complete financial analysis of Endexx Corporation (EDXC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Endexx Corporation, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Société Anonyme des Bains de Mer et du Cercle des Étrangers à Monaco (BAIN.PA) Income Statement Analysis – Financial Results
- Uttam Sugar Mills Limited (UTTAMSUGAR.BO) Income Statement Analysis – Financial Results
- Exelixis, Inc. (EXEL) Income Statement Analysis – Financial Results
- Profit Cultural and Creative Group Co., Ltd. (300640.SZ) Income Statement Analysis – Financial Results
- Airthings ASA (ARTGF) Income Statement Analysis – Financial Results
Endexx Corporation (EDXC)
About Endexx Corporation
Endexx Corporation engages in the manufacturing and sale of cannabidiol (CBD)-based products for the health and wellness market. It provides CBD creams, oils, capsules, extracts, topicals, drinks, chocolates, and pet products, as well as hemp-derived health and beauty care products for supporting the therapeutic relief of pain and inflammation for humans and pets through its e-commerce site cbdunlimited.com, as well as other online and in-store retailers. The company was formerly known as CBD Unlimited, Inc. and changed its name to Endexx Corporation in May 2020. Endexx Corporation is headquartered in Cave Creek, Arizona.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.91M | 1.28M | 650.52K | 1.97M | 1.50M | 797.55K | 418.39K | 220.76K | 126.26K | 34.64K | 0.00 |
Cost of Revenue | 5.06M | 774.57K | 994.59K | 606.62K | 823.58K | 449.25K | 212.46K | 166.54K | 115.72K | 732.00 | 0.00 |
Gross Profit | -1.15M | 503.01K | -344.08K | 1.36M | 674.49K | 348.30K | 205.93K | 54.22K | 10.54K | 33.91K | 0.00 |
Gross Profit Ratio | -29.39% | 39.37% | -52.89% | 69.22% | 45.02% | 43.67% | 49.22% | 24.56% | 8.35% | 97.89% | 0.00% |
Research & Development | 5.25K | 27.07K | 10.15K | 15.27K | 20.72K | 43.64K | 8.11K | 18.74K | 57.47K | 115.99K | 2.00K |
General & Administrative | 0.00 | 3.25M | 3.22M | 3.50M | 3.30M | 1.06M | 449.88K | 763.69K | 879.84K | 533.87K | 234.70K |
Selling & Marketing | 0.00 | 564.08K | 1.78M | 445.14K | 255.90K | 108.10K | 52.27K | 41.83K | 36.97K | 59.38K | 0.00 |
SG&A | 4.09M | 3.82M | 5.00M | 3.95M | 3.30M | 1.17M | 502.14K | 805.53K | 916.82K | 593.25K | 234.70K |
Other Expenses | 0.00 | 20.61K | 20.40K | 15.45K | 25.18K | 65.05K | 2.64K | 2.64K | 67.72K | 35.78K | -599.00 |
Operating Expenses | 4.09M | 3.87M | 5.03M | 3.98M | 3.35M | 1.22M | 512.90K | 826.92K | 976.72K | 710.32K | 237.07K |
Cost & Expenses | 9.15M | 4.64M | 6.02M | 4.59M | 4.17M | 1.67M | 725.36K | 993.45K | 1.09M | 710.32K | 237.07K |
Interest Income | 0.00 | 1.24M | 950.55K | 3.13M | 1.48M | 0.00 | 0.00 | 0.00 | 0.00 | 2.00 | 0.00 |
Interest Expense | 3.80M | 1.24M | 950.55K | 3.13M | 1.90M | 435.72K | 306.75K | 3.97K | 270.99K | 2.00 | 0.00 |
Depreciation & Amortization | 9.67K | 20.61K | 20.40K | 15.45K | 17.42K | 10.64K | 2.64K | 2.64K | 2.43K | 1.08K | -374.00 |
EBITDA | -4.67M | -3.65M | -5.37M | -5.73M | -6.78M | -1.33M | -276.13K | -770.05K | -896.03K | -674.60K | -236.70K |
EBITDA Ratio | -119.45% | -352.65% | -1,020.65% | -146.48% | -585.00% | -100.28% | -72.74% | -348.83% | -709.65% | -2,616.83% | 0.00% |
Operating Income | -5.24M | -3.36M | -5.37M | -2.62M | -2.67M | -867.48K | -306.97K | -772.70K | -966.18K | -675.68K | -237.07K |
Operating Income Ratio | -134.08% | -263.17% | -825.70% | -132.73% | -178.50% | -108.77% | -73.37% | -350.02% | -765.21% | -1,950.57% | 0.00% |
Total Other Income/Expenses | -3.23M | -1.23M | -1.44M | -5.45M | -3.99M | -1.63M | -361.76K | -3.97K | -84.16K | 267.66K | -599.00 |
Income Before Tax | -8.47M | -4.13M | -6.81M | -8.06M | -9.66M | -1.74M | -668.73K | -776.66K | -1.17M | -408.02K | -237.67K |
Income Before Tax Ratio | -216.81% | -323.19% | -1,046.58% | -409.01% | -644.73% | -217.94% | -159.83% | -351.82% | -926.20% | -1,177.88% | 0.00% |
Income Tax Expense | -1.98M | 766.71K | 950.55K | 3.13M | 1.73M | -434.95K | 306.75K | -1.00 | 338.71K | -231.87K | 747.00 |
Net Income | -6.50M | -4.90M | -7.76M | -11.19M | -11.39M | -1.74M | -668.73K | -776.66K | -1.17M | -408.02K | -237.67K |
Net Income Ratio | -166.26% | -383.20% | -1,192.70% | -567.92% | -760.28% | -217.94% | -159.83% | -351.82% | -926.20% | -1,177.89% | 0.00% |
EPS | -0.01 | -0.01 | -0.02 | -0.03 | -0.03 | -0.01 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
EPS Diluted | -0.01 | -0.01 | -0.02 | -0.03 | -0.03 | -0.01 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
Weighted Avg Shares Out | 504.71M | 503.98M | 455.05M | 379.17M | 343.49M | 289.10M | 259.70M | 235.54M | 216.32M | 211.71M | 199.04M |
Weighted Avg Shares Out (Dil) | 504.71M | 503.98M | 455.05M | 379.17M | 343.49M | 289.10M | 262.47M | 235.54M | 216.32M | 211.71M | 199.04M |
Endexx Registration Statement on Form 10 Completed
Endexx and DJ Khaled promote BLESSWELL CBD grooming products for healthy summertime skin and hair
Endexx says international subsidiary granted ‘Herb House' license to sell cannabis in Jamaica
Endexx's International Division, Go Green Global, Granted Retailer Herb House License in Jamaica
Endexx partnership with Grammy winner DJ Khaled looks even better after unveiling BLESSWELL CBD grooming products
DJ Khaled Expands his Empire with the Launch of BLESSWELL, A Line of CBD-enhanced Men's Grooming Products
Endexx Contracts Beauty Barrage to Drive New Cosmetic Brand
Endexx Files Amended Form 10 Including Fiscal 2020 PCAOB Audited Financials
Endexx Files Form 10 Registration Statement for SEC Review
Source: https://incomestatements.info
Category: Stock Reports